GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CARsgen Therapeutics Holdings Ltd (OTCPK:CRTHF) » Definitions » Additional Paid-In Capital

CRTHF (CARsgen Therapeutics Holdings) Additional Paid-In Capital : $1,294.11 Mil(As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is CARsgen Therapeutics Holdings Additional Paid-In Capital?


CARsgen Therapeutics Holdings's quarterly additional paid-in capital increased from Jun. 2023 ($1,317.45 Mil) to Dec. 2023 ($1,321.66 Mil) but then stayed the same from Dec. 2023 ($1,321.66 Mil) to Jun. 2024 ($1,294.11 Mil).

CARsgen Therapeutics Holdings's annual additional paid-in capital declined from Dec. 2021 ($1,478.94 Mil) to Dec. 2022 ($1,352.66 Mil) and declined from Dec. 2022 ($1,352.66 Mil) to Dec. 2023 ($1,321.66 Mil).

CARsgen Therapeutics Holdings Additional Paid-In Capital Historical Data

The historical data trend for CARsgen Therapeutics Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CARsgen Therapeutics Holdings Additional Paid-In Capital Chart

CARsgen Therapeutics Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
- - 1,478.94 1,352.66 1,321.66

CARsgen Therapeutics Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1,352.66 1,317.45 1,321.66 1,294.11

CARsgen Therapeutics Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

CARsgen Therapeutics Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of CARsgen Therapeutics Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

CARsgen Therapeutics Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CARsgen Therapeutics Holdings Ltd (OTCPK:CRTHF) » Definitions » Additional Paid-In Capital
Comparable Companies
HKSE:02487 HKSE:02157 HKSE:00775 HKSE:02480 HKSE:02179 HKSE:01477 HKSE:02696 HKSE:06855 HKSE:06955 HKSE:02315 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
02171:Hong Kong
Address
No. 466 Yindu Road, Building 2, 1st Floor, Xuhui District, Shanghai, CHN
Website
https://www.carsgen.com
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America.

CARsgen Therapeutics Holdings Headlines

No Headlines